期刊文献+

老年肺炎及肺癌合并感染伴胸腔积液者心功能不全的临床观察 被引量:3

Clinical observation of cardiac insufficiency in those elderly with senile pneumonia or lung cancer accompanied by pleural effusion
下载PDF
导出
摘要 目的探讨心功能不全与老年肺炎及肺癌伴胸腔积液的相关性。方法采用前瞻性对照研究,57例人选病例按病因诊断分为2组:肺炎合并胸腔积液组30例(肺炎组),肺癌合并感染伴胸腔积液组27例(肺癌组)。2组患者在对症治疗的基础上采用相同原则抗感染和强心、利尿的治疗措施。所有患者入院后依据NYHA分级标准评定心功能(Cardiacfunctionclassification,CFC);并于入院后第1d和治疗后7d,为患者做胸部CT检查,超声测定心脏左心室舒张末内径(LVEDD)和左心室射血分数(LVEF),并同时检测血浆B型钠尿肽(BNP)浓度。结果肺炎组心衰的患病率(86.7%)明显高于肺癌组(14.8%),P〈0.01。治疗前肺炎组LVEF低于肺癌组(43.58±4.16比59.11±6.35,P〈0.01);LVEDD高于肺癌组(62.43±7.94比48.18±5.12,P〈0.01);BNP明显高于肺癌组(582.67±126.53比146.27±43.77),差异有统计学意义,P〈0.01。治疗7d后,肺炎组LVEF增加、LVEDD减小和BNP下降与治疗前比较,差异有统计学意义,P〈0.01;而肺癌组治疗前后LVEF、LVEDD和BNP均无明显变化,P〉0.05。肺炎组胸腔积液的治疗效果[70.0%(21/30)的患者完全吸收,16.7%(5/30)部分吸收,13.3%(4/30)无吸收]明显优于肺癌组[18.5%±5/27)部分吸收,81.5%(22,27)无吸收,P〈0.05]。结果表明,肺炎组的治疗效果与BNP下降、LVEDD减小和LVEF增加相一致。结论心功能不全在老年肺炎伴胸腔积液者有很高的发生率,动态监测患者BNP水平、LVEF和LVEDD的变化,对指导心功能不全相关性胸腔积液的诊断和治疗有重要的临床意义。 Objective To observe the correlation between cardiac insufficiency and pleura] effusion in elderly who were suffering from pneumonia or lung cancer. Methods A prospective study was carried out to investigate 57 emergently hospitalized patients with pleura] effusion, and according to the etiology, they were divided into two groups: a senile pneumonia group (30 cases) and a lung cancer group (27 cases). The same therapeutic measures were taken in the two groups, such as, anti-infection, enhancement of cardiac function, dieresis, and limitation of the amount of liquid intake. After admission, every patient' s cardiac function was determined according to the gradation of the New York Heart Association (NYHA). Respectively, all the patients took the CT scan of the chest before the treatment and on the 7th day after treatment, and at the same time, left ventricular end-diastolic diameter (LVEDD), left ventricular ejection Fraction (LVEF) and plasma concentrations of B-type natriuretic peptide (BNP) were detected. Results 1. The incidence of congestive heart failure (CHF) in pneumonia group was significantly higher than that in lung cancer group (86.7% vs. 14.8%, P〈 0.01). 2. Before treatment, LVEF in pneumonia group was lower than that in group of lung cancer (43.58±4.16 vs.59.11±6.35, P〈0.01), LVEDD and BNP were significantly higher than that in lung cancer group (62.43±7.94 vs.48.18± 5.12; 582.67 ± 126.53 vs.146.27 ±43.77, respectively, P〈 0.01). Compared that with before treatment, after treatment the BNP and LVEDD declined down and LVEF increased up in pneumonia group (P〈 0.01). Nevertheless, LVEDD or LVEF and BNP no vary in lung cancer group (P 〉0.05). 3. The therapeutic effect that pleura] effusion was absorbed in pneumonia group [% (cases) ] was much superior to that in lung cancer group [completely 86.7% (21/30), partly 16.7% (5/30) and no 13.3% (4/30) vs. respectively 0(0/27),18.5%(5/27) and 81.5%(22/27), P〈 0.013
作者 李樱 孙中吉
出处 《中国急救复苏与灾害医学杂志》 2014年第4期311-314,共4页 China Journal of Emergency Resuscitation and Disaster Medicine
关键词 胸腔积液 心力衰竭 B型钠尿肽 左室舒张末内径 左室射血分数 Pleural effusion Congestive heart failure B-type natriuretic peptide Left ventriculardiastolic diameter Left ventricular ejection fraction
  • 相关文献

参考文献12

  • 1任众环,王金良.B型钠尿肽在诊治充血性心力衰竭中的价值[J].中国中西医结合急救杂志,2003,10(5):319-320. 被引量:21
  • 2Anderson KM. Clinical uses of brain uatriurefic pcptidc in diagnosing and managing heart failure. J Am Acad Nurse Pract, 2008, 20(6): 305-310. 被引量:1
  • 3Jeevanantham V, Shrivastava R, Nannapaneni S, et al. Elevated B-type natriuretic peptide level: use with caution in patients with multiple co-morbidities and presenting with dyspnea. Indian Heart J, 2007, 59(1): 64-68. 被引量:1
  • 4Gegenhuber A, Mueller T, Dieplinger B, et al. Plasma B-type natriuretic peptide in patients with pleural effusions: preliminary observations. Chest, 2005,128(2):1003-1009. 被引量:1
  • 5Porcel JM, Martinez-Alonso M, Cao G,et al. Biomarkcrs of heart failure in pleurai fluid. Chest, 2009,136(3):671-677. 被引量:1
  • 6Long AC,O'Neai HR Jr, Peng S,et al. Comparison of pleurai fluid N-terminai pro-brain natriuretic peptide and brain natriuretic-32 peptide levels. Chest, 2010,137(6):1369-1374. 被引量:1
  • 7Marinho FC, Vaxgas FS, Fabri J Jr,et ai. Clinical usefulness of B-type natriuretic peptide in the diagnosis of pleural effusions due to heart failure. Respirology. 2011,16(3):495-499. 被引量:1
  • 8Emdin M, Passino C, Prontera C, et al. Comparison of brain natriurctic peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure.Clin Chore, 2007,53(7): 1289-1297. 被引量:1
  • 9邹国辉,刘中勇,张丽,刘福水.强心合剂对充血性心力衰竭患者血浆脑钠素水平的影响[J].中国中西医结合急救杂志,2006,13(2):83-85. 被引量:12
  • 10Jourdain P,Jondeau G,Funck F,et al.Plasmabrain natriuretic peptide-guided therapy to improve outcome in heart failure: the stars-BNP muhicenter study. J Am Coll Cardiol, 2007,49(16): 1733-1739. 被引量:1

二级参考文献85

共引文献86

同被引文献22

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部